Journal
Nephrology dialysis transplantation
Publication Date
3-31-2023
Volume
38
Issue
4
First Page
894
Last Page
903
Document Type
Open Access Publication
DOI
10.1093/ndt/gfac198
Rights and Permissions
Jennifer B Green, Amy K Mottl, George Bakris, Hiddo J L Heerspink, Johannes F E Mann, Janet B McGill, Masaomi Nangaku, Peter Rossing, Charlie Scott, Alain Gay, Rajiv Agarwal, Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE), Nephrology Dialysis Transplantation, Volume 38, Issue 4, April 2023, Pages 894–903, https://doi.org/10.1093/ndt/gfac198. https://academic.oup.com/ndt/article/38/4/894/6608366?login=true. © The Author(s) 2022. Published by Oxford University Press on behalf of the ERA. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com.
Recommended Citation
Green, Jennifer B; Mottl, Amy K; Bakris, George; Heerspink, Hiddo J L; Mann, Johannes F E; McGill, Janet B; Nangaku, Masaomi; Rossing, Peter; Scott, Charlie; Gay, Alain; and Agarwal, Rajiv, "Design of the COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint study (CONFIDENCE)." Nephrology dialysis transplantation. 38, 4. 894 - 903. (2023).
https://digitalcommons.wustl.edu/oa_4/1458
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
